ATE474570T1 - Pharmazeutische zubereitung zur verwendung in der therapie oder prophylaxe von neoplastischen erkrankungen - Google Patents

Pharmazeutische zubereitung zur verwendung in der therapie oder prophylaxe von neoplastischen erkrankungen

Info

Publication number
ATE474570T1
ATE474570T1 AT06700207T AT06700207T ATE474570T1 AT E474570 T1 ATE474570 T1 AT E474570T1 AT 06700207 T AT06700207 T AT 06700207T AT 06700207 T AT06700207 T AT 06700207T AT E474570 T1 ATE474570 T1 AT E474570T1
Authority
AT
Austria
Prior art keywords
prophylaxis
therapy
glutamine
pharmaceutical preparation
alpha
Prior art date
Application number
AT06700207T
Other languages
English (en)
Inventor
Stephan Pyerzynowski
Martyna Kandefer-Szerszen
Wojciech Rzeski
Original Assignee
Sgp & Sons Ab
Pierzynowski Stefan G
Martyna Kandefer-Szerszen
Wojciech Rzeski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sgp & Sons Ab, Pierzynowski Stefan G, Martyna Kandefer-Szerszen, Wojciech Rzeski filed Critical Sgp & Sons Ab
Application granted granted Critical
Publication of ATE474570T1 publication Critical patent/ATE474570T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT06700207T 2005-01-11 2006-01-10 Pharmazeutische zubereitung zur verwendung in der therapie oder prophylaxe von neoplastischen erkrankungen ATE474570T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL372183A PL372183A1 (pl) 2005-01-11 2005-01-11 Preparat przeciwnowotworowy oraz zastosowanie preparatu przeciwnowotworowego
PCT/PL2006/000003 WO2006075924A1 (en) 2005-01-11 2006-01-10 Antineoplastic preparation and the use of antineoplastic preparation

Publications (1)

Publication Number Publication Date
ATE474570T1 true ATE474570T1 (de) 2010-08-15

Family

ID=36168380

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06700207T ATE474570T1 (de) 2005-01-11 2006-01-10 Pharmazeutische zubereitung zur verwendung in der therapie oder prophylaxe von neoplastischen erkrankungen

Country Status (12)

Country Link
US (1) US7759396B2 (de)
EP (1) EP1845966B1 (de)
JP (2) JP2008526838A (de)
CN (1) CN101111241B (de)
AT (1) ATE474570T1 (de)
AU (1) AU2006205279B2 (de)
CA (1) CA2593780C (de)
DE (1) DE602006015608D1 (de)
DK (1) DK1845966T3 (de)
ES (1) ES2349233T3 (de)
PL (2) PL372183A1 (de)
WO (1) WO2006075924A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2033623A1 (de) 2007-09-07 2009-03-11 Cutech S.R.L. Zusammensetzungen mit Ornithinketoglutarat (OKG)
CN113082009A (zh) * 2014-02-12 2021-07-09 加利福尼亚大学董事会 用于治疗衰老和与年龄相关的疾病和症状的组合物和方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
FR2775901B1 (fr) * 1998-03-13 2000-07-21 Logeais Labor Jacques Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments
SE0201713D0 (sv) * 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
ES2405287T3 (es) * 2002-08-01 2013-05-30 Eisai Inc. Tratamiento mejorado del cáncer con glutamina
AT412447B (de) * 2002-11-27 2005-03-25 C Y L Handelsges M B H Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung
ATE342722T1 (de) * 2003-05-07 2006-11-15 Osteologix As Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
US20050124684A1 (en) * 2003-08-29 2005-06-09 Ying Du 5-(hydroxymethyl) furfural and derivatives as inhibitors of TNFalpha and IL-1beta production
EP1824470B1 (de) 2004-12-17 2014-08-06 Alan B. Cash Verfahren zur verlängerung der lebensdauer und zur verzögerung des einsetzens von altersbedingten krankheiten

Also Published As

Publication number Publication date
AU2006205279A1 (en) 2006-07-20
AU2006205279B2 (en) 2011-05-26
DE602006015608D1 (de) 2010-09-02
WO2006075924A1 (en) 2006-07-20
JP2013035864A (ja) 2013-02-21
CN101111241A (zh) 2008-01-23
US7759396B2 (en) 2010-07-20
EP1845966B1 (de) 2010-07-21
PL1845966T3 (pl) 2011-02-28
CA2593780C (en) 2013-11-26
DK1845966T3 (da) 2010-11-08
JP2008526838A (ja) 2008-07-24
CA2593780A1 (en) 2006-07-20
CN101111241B (zh) 2010-12-01
US20080058422A1 (en) 2008-03-06
ES2349233T3 (es) 2010-12-29
PL372183A1 (pl) 2006-07-24
EP1845966A1 (de) 2007-10-24

Similar Documents

Publication Publication Date Title
TNSN07452A1 (en) Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
IL185428A0 (en) 2-[isoquinolin-3- carbonyl) amino] - propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
AU2008267058A8 (en) Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
UY27720A1 (es) Aroilpiridinonas monocíclicas,
BRPI0606301A2 (pt) processo para fabricar uma mistura de sais de acetato de polipeptìdeos, processo para fabricar uma mistura de sais de polipeptìdeos de trifluoroacetila não protegidos, mistura de sais de acetato de polipeptìdeos, composição farmacêutica, processos para a preparação de uma composição farmacêutica, e, mistura de polipeptìdeos de trifluoroacetila protegidos
WO2011107653A8 (en) Use of levodopa, carbidopa and entacapone for treating parkinson's disease
ATE510537T1 (de) Pharmazeutische zusammensetzungen von entacapon, levodopa und carbidopa mit verbesserter bioverfügbarkeit
CO6290629A2 (es) Composiciones de limpieza de amino ácido básico y métodos
ATE366106T1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
DK1290011T3 (da) Melphalan-derivater og deres anvendelse som cancer-kemoterapeutiske lægemidler
EA201100063A1 (ru) СПОСОБ ПОЛУЧЕНИЯ ПИРИДО-ПИРИМИДИНОВЫХ ИНГИБИТОРОВ mTOR КИНАЗЫ, ИХ СОЛЕВЫХ ФОРМ И ИХ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
ATE486620T1 (de) Biomimetisches verfahren zur beschichtung von substraten
WO2006062424A3 (en) Use of 3-hydroxy-3-methylbutyrate alone or in combination with alpha-ketoglutarate in the growth and mineralisation of the osteo-skeletal system
TNSN07228A1 (en) Manufacture process of organic compounds
ATE474570T1 (de) Pharmazeutische zubereitung zur verwendung in der therapie oder prophylaxe von neoplastischen erkrankungen
WO2021239928A3 (en) Treatment of cardiometabolic disease with inhibitors of type i interferon signalling
WO2007000001A3 (en) Pleuromutilin salts with salicylic acid, azelaic acid, sebacic acid and diclofenac
TW200612922A (en) Inhibitors of hsp90
MXPA05006408A (es) Derivados deuterizados de catecolamina y medicamentos comprendiendo estos compuestos.
ATE538782T1 (de) Modifizierte aminosaeure 5-cnac zur hemmung der thrombozytenaggregation
ATE516040T1 (de) Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis
UA83900C2 (en) Amorphous forms of risedronate monosodium
PT1284945E (pt) Fertilizante contendo azoto para o crescimento de plantas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties